interferon beta-1a

FDA Drug Profile — AVONEX, Rebif, REBIF

Drug Details

Generic Name
interferon beta-1a
Brand Names
AVONEX, Rebif, REBIF
Application Number
BLA103628
Sponsor
Biogen Inc.
NDC Codes
5
Dosage Forms
KIT, LIQUID, INJECTION, SOLUTION
Routes
INTRAMUSCULAR, SUBCUTANEOUS
Active Ingredients
INTERFERON BETA-1A

Indications and Usage

1 INDICATIONS AND USAGE AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. AVONEX is for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )